Qiu HX - Search Results

1

[Interdigitating dendritic cell sarcoma-a case report with literature review].

Gao WJ, Zhang R, Qiu HX, Shen YM, Zhang XH, Xue SL, Han Y. Gao WJ, et al. Among authors: qiu hx. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):232-4. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 15949268 Review. Chinese.

2

[Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].

Xu W, Li JY, Zhang ZH, Qiu HX, Qian SX, Wu HX, Lu H, Sheng RL. Xu W, et al. Among authors: qiu hx. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):933-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718094 Clinical Trial. Chinese.

3

[Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab].

Gu WJ, Xu W, Qian SX, Wu YJ, Hong M, Chen LJ, Wu HX, Lu H, Qiu HX, Li JY. Gu WJ, et al. Among authors: qiu hx. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):938-42. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718095 Clinical Trial. Chinese.

4

[Clinical study of bortezomib in combination with dexamethasone for the treatment of multiple myeloma].

Wang LX, Lu H, Shen WY, Qian SX, Qiu HX, Wu HX, Zhang JF, Wu YJ, Li JY. Wang LX, et al. Among authors: qiu hx. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):943-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718096 Clinical Trial. Chinese.

5

[IgVH mutation status in patients with chronic lymphocytic leukemia].

Zhang YP, Chen LJ, Zheng WJ, Wu YJ, Qiu HX, Qian SX, Xu W, Li JY. Zhang YP, et al. Among authors: qiu hx. Zhonghua Xue Ye Xue Za Zhi. 2008 Mar;29(3):164-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18788614 Chinese.

6

[Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].

Xu W, Li JY, Li L, Wu YJ, Yu H, Shen QD, Qiu HX. Xu W, et al. Among authors: qiu hx. Zhonghua Xue Ye Xue Za Zhi. 2008 Jul;29(7):450-3. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 19035176 Chinese.

7

[Standard-dose of idarubicin in combination with continuous infusion of cytarabine as induction therapy in patients with acute myeloid leukaemia].

Qian SX, Li JY, Wu HX, Lu H, Qiu HX, Chen LJ, Lu RN, Xu W, Sheng RL. Qian SX, et al. Among authors: qiu hx. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):209-13. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19236781 Clinical Trial. Chinese.

8

[IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia].

Qian SX, Li JY, Wu HX, Zhang R, Hong M, Xu W, Qiu HX. Qian SX, et al. Among authors: qiu hx. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):464-7. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19379589 Clinical Trial. Chinese.

9

[Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in 50 patients with relapsed acute myeloid leukemia].

Zhu BG, Qian SX, Hong M, Lu H, Wu HX, Zhang SJ, Qiu HX, Xu W, Li JY. Zhu BG, et al. Among authors: qiu hx. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):760-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549403 Clinical Trial. Chinese.

10

[Efficacy of IA regimen followed by FLAG regimen in the treatment of acute myeloid leukaemia].

Qian SX, Li JY, Hong M, Lu H, Wu HX, Qiu HX, Zhang SJ, Chen LJ, Xu W, Sheng RL. Qian SX, et al. Among authors: qiu hx. Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):22-5. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19563030 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters